The company cites current market conditions as the reason to seek withdrawal of the registration statement and declares that no securities covered by the registration statement have been issued or sold. Furthermore, the company requested that all fees paid to the SEC in connection with the filing be credited for future use.
According to a report from the Denver Business Journal, the company initially filed with the SEC last year to list its common stock on the New York Stock Exchange with an initial public offering valuation of $100 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
